What is an overview of thyroid eye disease, including its introduction, staging, diagnosis, and management?

Thyroid Eye Disease: Overview

Introduction

Thyroid eye disease (TED) is an autoimmune disorder characterized by orbital and periorbital tissue inflammation and congestion, leading to soft tissue swelling, eyelid retraction, exophthalmos, restrictive extraocular myopathy, and potentially optic neuropathy. 1 The condition affects adults primarily in their fourth to fifth decade of life, with a striking female predominance (8:1 ratio) and an incidence of 16 per 100,000 per year in women versus 2.9 per 100,000 per year in men among Caucasian populations 1.

TED is now recognized as occurring not only with Graves hyperthyroidism but also in euthyroid and hypothyroid states 2. The disease causes significant morbidity through facial disfigurement, diplopia, dry eyes, and in severe cases, vision loss, profoundly impacting quality of life with substantial socioeconomic consequences 1.

Key Risk Factors

The following factors increase both risk and severity of TED 1:

• Smoking (most modifiable risk factor)
• Diseases causing reduced oxygen saturation (emphysema)
• Exposure to ionizing radiation
• Radioactive iodine treatment
• High anti-thyroid antibody titers
• Serum vitamin D deficiency
• Prior orbital decompression (increases strabismus risk, worsens with age)

Staging and Natural History

Between 30-50% of TED patients develop restrictive myopathy, with ocular motility initially restricted by inflammatory edema and later by fibrosis. 1 The disease follows a biphasic course:

Active (Inflammatory) Phase

• Characterized by orbital congestion and edema
• Extraocular muscle inflammation
• Progressive symptoms

Inactive (Fibrotic) Phase

• Muscle fibrosis predominates
• Stable but persistent restrictions
• Surgical intervention timing depends on reaching this phase

Muscle Involvement Pattern

The inferior rectus is most frequently affected, followed by the medial rectus, though global extraocular muscle involvement is common 1. This pattern typically produces hypotropia with esotropia as the most frequent deviation.

Severity Classification

TED should be categorized as:

• Mild: Minimal impact on function
• Moderate-to-severe: Significant functional impairment, diplopia, or cosmetic concerns
• Sight-threatening: Compressive optic neuropathy or severe exposure keratopathy requiring urgent intervention 1, 3

Diagnosis

History Taking

Obtain specific information about 4:

• Thyroid symptoms: Weight changes, tachycardia, unexplained fatigue
• Visual symptoms: Diplopia, blurred vision, eye pain
• Compensatory head posture (often chin-up position)
• Smoking history and quantification
• Previous thyroid treatments (especially radioactive iodine)
• Screen for myasthenia gravis (increased incidence in TED patients)

Clinical Examination

A comprehensive sensorimotor examination must document mechanical restriction evidence 4:

Essential Components:

• Visual acuity at distance and near
• Exophthalmometry measurement (critical for diagnosis and monitoring)
• Forced duction testing to confirm restriction
• Fixation duress assessment: Look for brow elevation and augmented eyelid retraction on attempted upgaze
• Binocular field testing to map single vision regions
• Uniocular fields of fixation to measure and monitor duction deficits
• IOP measurement (may be elevated, especially in upgaze)
• Corneal examination for exposure keratopathy
• Optic nerve assessment for compressive neuropathy signs

Classic Ocular Findings 1:

• Soft tissue congestion with preseptal fat pad enlargement
• Eyelid retraction
• Exophthalmos
• Restrictive extraocular myopathy
• Optic neuropathy (in severe cases)

Imaging

MRI or CT is helpful in confirming diagnosis and assessing extraocular muscle involvement 1. Imaging demonstrates characteristic muscle enlargement with tendon sparing and can identify orbital apex crowding suggesting compressive optic neuropathy risk.

Management

Priority Framework

Treatment is symptom-directed with the primary goal of preventing vision loss, followed by restoring function and improving quality of life 1. Management follows this hierarchy:

1. Vision-Threatening Disease (Immediate Referral Required)

Refer immediately to an orbital specialist if 1:

• Compressive optic neuropathy (crowding at orbital apex)
• Severe exposure keratopathy
• Moderate-to-severe exophthalmos with significant orbital pain

2. Active Disease Management

• Smoking cessation is mandatory (modifiable risk factor)
• Coordinate with endocrinology to optimize thyroid function
• Monitor for disease activity and progression
• Consider emerging targeted therapies (teprotumumab for active disease) 5, 6

3. Symptomatic Management

For exposure keratopathy:

• Aggressive lubrication
• Nighttime ointment and taping if needed
• Consider oculoplastic referral for definitive eyelid management

For diplopia and strabismus:

• Prism therapy during active phase
• Delay strabismus surgery until disease is inactive (stable for 6+ months)
• Goal: Re-establish single binocular vision in primary gaze and reading position 1

For elevated IOP:

• Monitor carefully, especially in upgaze
• Treat as indicated to prevent glaucomatous damage

4. Surgical Rehabilitation Sequence

When disease is inactive, follow this order:

1. Orbital decompression (if needed for proptosis or optic neuropathy)
2. Strabismus surgery (after decompression, as it affects alignment)
3. Eyelid surgery (final step after alignment established)

Emerging Therapies

Recent advances include 5, 6:

• Teprotumumab (FDA-approved IGF-1 receptor inhibitor): Reduces proptosis and improves diplopia
• Alternative IGF-1 receptor antagonists in development
• FcRn inhibitors
• Interleukin pathway antagonists
• TSH receptor inhibitors

Common Pitfalls to Avoid

1. Operating during active disease phase leads to unpredictable outcomes and recurrence
2. Failing to screen for myasthenia gravis in TED patients
3. Missing compressive optic neuropathy by not carefully assessing color vision, relative afferent pupillary defect, and visual fields
4. Not measuring IOP in upgaze where it may be significantly elevated
5. Performing strabismus surgery before orbital decompression when both are needed
6. Inadequate smoking cessation counseling despite its major impact on disease severity

Multidisciplinary Coordination

Inform the patient's other healthcare providers about the diagnosis and work collaboratively on the treatment plan 1. TED management requires coordination among primary care, endocrinology, ophthalmology (general and oculoplastic), and potentially neuro-ophthalmology for complex cases.